Abivax names new global heads of marketing, sales and market access in commercial leadership shake-up

Reuters2026/07/23 20:13

By:Reuters

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Abivax expanded its commercial leadership team with four senior hires as it prepares a potential US launch of obefazimod.
James Berger named global head of marketing; previously global franchise head for Amgen’s Tezspire, earlier helped launch Takeda’s Entyvio.
Ivan Nuñez-Pacheco appointed global head of patient services; previously senior director at AbbVie Patient Services supporting Humira, Skyrizi, Rinvoq programs.
Heather Dean hired as global head of sales, accounts, commercial operations; former Eli Lilly, Takeda executive involved in more than a dozen launches.
Jeff Haas named global head of market access, pricing; previously corporate vice president at Abbott, earlier held market access roles at Abbott, AbbVie.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Abivax SA published the original content used to generate this news brief via EQS News (Ref. ID: fr_reg_2370996_fr) on July 23, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Abivax names new global heads of marketing, sales and market access in commercial leadership shake-up

You may also like

Crypto prices